1.
Blood Cancer J
; 13(1): 150, 2023 09 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37752126
Assuntos
Leucemia-Linfoma Linfoblástico de Células Precursoras , Criança , Humanos , Lactente , Austrália/epidemiologia , Nova Zelândia/epidemiologia , Progressão da Doença , Leucemia-Linfoma Linfoblástico de Células Precursoras/epidemiologia , Leucemia-Linfoma Linfoblástico de Células Precursoras/terapia , Sobreviventes
2.
J Pediatr Hematol Oncol
; 41(8): 620-623, 2019 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29889804
RESUMO
In this report, we present a young infant with multisystem Langerhans cell histiocytosis, who after cladribine and cytarabine salvage treatment developed immune thrombocytopenia (IT). On review of the literature, there were no previous reports of Langerhans cell histiocytosis-associated IT. Treatment of the IT with intravenous immunoglobulin and oral corticosteroids was unsuccessful. Eltrombopag, in combination with a 4-day course of dexamethasone was commenced as second-line therapy. Platelet recovery occurred 10 days after initiation of eltrombopag. The immune thrombocytopenia remains in long-term remission despite cessation of eltrombopag. Eltrombopag was safe and well tolerated.